| 低分子肝素防治脓毒症机制的研究进展 |
| |
| 引用本文： | 卢骁,赵良. 低分子肝素防治脓毒症机制的研究进展[J]. 中国急救医学, 2008, 28(11): 1033-1036 |
| |
| 作者姓名： | 卢骁 赵良 |
| |
| 作者单位： | 解放军第二军医大学附属长征医院急救科ICU,上海,200003 |
| |
| 基金项目： | 解放军第二军医大学附属长征医院三重三优学科人才建设计划项目 |
| |
| 摘 要： | 目的 脓毒症的研究在过去四十年里取得了一定的进展,自人类重组活化蛋白C的出现以来,我们已认识到凝血系统紊乱在脓毒症中的重要地位,而低分子肝素作为在临床上广泛使用的抗凝药物,现已发现其在脓毒症的各个环节都有其阻断作用,本文就其机制做一综述.
|
| 关 键 词： | 脓毒症 低分子肝素 |
Study on prevention and cure of sepsis by low molecular weight heparin |
| |
| LU Xiao,ZHAO Liang. Study on prevention and cure of sepsis by low molecular weight heparin[J]. Chinese Journal of Critical Care Medicine, 2008, 28(11): 1033-1036 |
| |
| Authors: | LU Xiao ZHAO Liang |
| |
| Affiliation: | LU Xiao,ZHAO Liang.ICU,Changzheng Hospital,the Second Military Medical University of PLA,Shanghai 200003,China |
| |
| Abstract: | There is some progress on the study of sepsis in past 40 years.When rhAPC comes out,we have known the importance of blood coagulation function imbalance caused by sepsis.Low molecular weight heparin has been widely used in hospital as anticoagulant.We discover it can block sepsis in many experiments,in this article,we summarize its mechanism. |
| |
| Keywords: | Sepsis Low molecular weight heparin |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
